The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
196
3900 mg/Day
Mean Reduction From Baseline in Menstrual Blood Loss (MBL)
reduction of menstrual blood loss in mL
Time frame: Baseline MBL over 6 menstrual cycles
Patient Reported Outcome Measure of Limitations in Social or Leisure Activities Associated With Heavy Menstrual Bleeding
A positive unit change mean relects an improvement from baseline. Patient reported outcome scores had the following response categories: 1=not limited at all; 2=slightly limited; 3=moderately limited; 4=quite a bit limited; and 5=extremely limited
Time frame: Change from Baseline scores over 6 menstrual cycles
Patient Reported Outcome Measure of Limitations in Physical Activities Associated With Heavy Menstrual Bleeding
A positive unit change mean relects an improvement from baseline. Patient reported outcome scores had the following response categories: 1=not limited at all; 2=slightly limited; 3=moderately limited; 4=quite a bit limited; and 5=extremely limited
Time frame: Change from Baseline scores over 6 menstrual cycles
Responder Analysis - Reduction in Large Stains
Percentage of subjects who experienced a reduction from baseline in the frequency of large stains
Time frame: Reduction from Baseline over 6 menstrual cycles
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Investigative Site
Tucson, Arizona, United States
Investigative Site
Tucson, Arizona, United States
Investigative Site
Little Rock, Arkansas, United States
Investigative Site
Carmichael, California, United States
Investigative Site
San Diego, California, United States
Investigative Site
Upland, California, United States
Investigative Site
Denver, Colorado, United States
Investigative Site
Lakewood, Colorado, United States
Investigative Site
Groton, Connecticut, United States
Investigative Site
West Hartford, Connecticut, United States
...and 42 more locations